Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2019 December;65(4) > Minerva Gastroenterologica e Dietologica 2019 December;65(4):280-90

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  INFLAMMATORY BOWEL DIESEASE: BEYOND THE EDGE 

Minerva Gastroenterologica e Dietologica 2019 December;65(4):280-90

DOI: 10.23736/S1121-421X.19.02625-4

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease

Daniela PUGLIESE 1 , Giuseppe PRIVITERA 2, Fabrizio PIZZOLANTE 1, Antonio GASBARRINI 2, 3, Luisa GUIDI 1, 2, Alessandro ARMUZZI 1, 2


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 45,00.

SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page